Source check: Source checked. Not independent scientific confirmation.
Finding: The study compared deep-learning-based image reconstruction (DLIR-H) with ASIR on low-dose pediatric chest CT, reporting image-quality and diagnostic performance measures in children with Mycoplasma pneumonia; this is a specific imaging result.
Technology: Deep-learning reconstruction DLIR-H reconstructs low-dose pediatric chest CT images for comparison with adaptive statistical iterative reconstruction (ASIR).
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Deep-learning reconstruction DLIR-H reconstructs low-dose pediatric chest CT images for comparison with adaptive statistical iterative reconstruction (ASIR).
- Test and result
- In 142 children with Mycoplasma pneumoniae pneumonia, DLIR-H had lower background noise and higher lesion contrast-to-noise ratio than ASIR-80%; radiologists gave it the highest subjective image-quality score.
- Limitation / still unknown
- Retrospective single-vendor study; lung-parenchyma SNR was lower with DLIR-H, diagnostic accuracy was not assessed, and prospective multicenter validation is needed.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.21037/tp-2025-1-923 · https://europepmc.org/article/MED/42158662 · https://europepmc.org/articles/PMC13181691 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC13181691/unicode · https://pubmed.ncbi.nlm.nih.gov/42158662/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Specific clinical post-treatment pathological reference target predicted from pre-treatment images; retain selection and therapy-response caveats without implying measured clinical benefit.
Technology: Specific clinical post-treatment pathological reference target predicted from pre-treatment images; retain selection and therapy-response caveats without implying measured clinical benefit.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Specific clinical post-treatment pathological reference target predicted from pre-treatment images; retain selection and therapy-response caveats without implying measured clinical benefit.
- Limitation / still unknown
- Full text reports the relevant cohort/measure, comparison or reference, and evaluation supporting this bounded claim.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11402411/ · https://pubmed.ncbi.nlm.nih.gov/39281097/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Source check: Source checked. Not independent scientific confirmation.
Finding: CT radiomics and 3D CNN classified calculous pyonephrosis in a retrospective 182-patient cohort; combined model AUC 0.967 on test data. This supports a narrow diagnostic-validation result, not clinical benefit.
Technology: Full text checked: Methods and Results report 123/59 train/test patients, LASSO radiomics and 3D CNN; test comparison against clinical model.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Full text checked: Methods and Results report 123/59 train/test patients, LASSO radiomics and 3D CNN; test comparison against clinical model.
- Test and result
- Full text checked: Methods and Results report 123/59 train/test patients, LASSO radiomics and 3D CNN; test comparison against clinical model.
- Limitation / still unknown
- Full text checked: Methods and Results report 123/59 train/test patients, LASSO radiomics and 3D CNN; test comparison against clinical model.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2306-5354/11/7/662 · https://pubmed.ncbi.nlm.nih.gov/39061744/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.